Cargando…
Clonal Myeloproliferative Disorders in Patients with Down Syndrome—Treatment and Outcome Results from an Institution in Argentina
SIMPLE SUMMARY: Around 30% of children with Down Syndrome (DS) will develop Transient Abnormal Myelopoiesis (TAM) and 20% of them will progress to Acute Myeloid Leukemia (AML), mostly Megakaryoblastic Leukemia (AMKL). The optimal balance between treatment intensity and treatment-related toxicity has...
Autores principales: | Pennella, Carla L., Cassina, Tamara Muñoz, Rossi, Jorge G., Baialardo, Edgardo M., Rubio, Patricia, Deu, María A., Peruzzo, Luisina, Guitter, Myriam R., Sanchez de La Rosa, Cristian G., Alfaro, Elizabeth M., Felice, María S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265690/ https://www.ncbi.nlm.nih.gov/pubmed/35805057 http://dx.doi.org/10.3390/cancers14133286 |
Ejemplares similares
-
Impact of IKZF1 Deletions in the Prognosis of Childhood Acute Lymphoblastic Leukemia in Argentina
por: Felice, María Sara, et al.
Publicado: (2022) -
2315. Neisseria meningitidis Oro-Pharyngeal Carriage, Serogroups and Clonal Complex in Children and Adolescents in Argentina
por: Gentile, Angela, et al.
Publicado: (2018) -
Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
por: Kjær, Lasse
Publicado: (2020) -
Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm
por: Fleischman, Angela G.
Publicado: (2015) -
Clonal Architecture in Myeloproliferative Neoplasms: Old Dog, New Tricks?
por: Godfrey, Anna L.
Publicado: (2023)